Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
SAGE

Sage Therapeutics

$162.11

0.11 (0.07%)

, BIIB

Biogen

$233.17

1.78 (0.77%)

11:40
04/04/19
04/04
11:40
04/04/19
11:40
Periodicals
Sage seen by sector advisor as 'good fit' for Biogen, Dealreporter says »

Three sector advisors…

SAGE

Sage Therapeutics

$162.11

0.11 (0.07%)

BIIB

Biogen

$233.17

1.78 (0.77%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Apr

  • 24

    Apr

  • 30

    Apr

  • 01

    May

Over a month ago
LGND

Ligand

$123.96

-0.2 (-0.16%)

, SAGE

Sage Therapeutics

$152.62

-3.46 (-2.22%)

09:11
03/21/19
03/21
09:11
03/21/19
09:11
Hot Stocks
Ligand to receive $3M milestone payment from FDA approval of ZULRESSO »

Ligand Pharmaceuticals…

LGND

Ligand

$123.96

-0.2 (-0.16%)

SAGE

Sage Therapeutics

$152.62

-3.46 (-2.22%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Mar

SAGE

Sage Therapeutics

$152.62

-3.46 (-2.22%)

18:39
03/20/19
03/20
18:39
03/20/19
18:39
Hot Stocks
Sage Therapeutics CEO: Postpartum depression is a medical issue »

In an interview on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALKS

Alkermes

$35.05

0.45 (1.30%)

, AVXL

Anavex

$2.96

-0.06 (-1.99%)

09:25
03/20/19
03/20
09:25
03/20/19
09:25
Hot Stocks
Pharma industry members launch ERP Biomarker Qualification Consortium »

The ERP Biomarker…

ALKS

Alkermes

$35.05

0.45 (1.30%)

AVXL

Anavex

$2.96

-0.06 (-1.99%)

HLUYY

Lundbeck

$0.00

(0.00%)

MRK

Merck

$81.93

0.59 (0.73%)

SAGE

Sage Therapeutics

$156.08

-0.89 (-0.57%)

TAK

Takeda Pharmaceutical

$21.26

-0.01 (-0.05%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

  • 25

    Mar

  • 05

    Apr

  • 11

    Apr

  • 30

    Apr

  • 18

    May

  • 17

    Jun

LGND

Ligand

$124.16

-0.45 (-0.36%)

, SAGE

Sage Therapeutics

$156.08

-0.89 (-0.57%)

07:36
03/20/19
03/20
07:36
03/20/19
07:36
Recommendations
Ligand, Sage Therapeutics analyst commentary at H.C. Wainwright »

Ligand receives royalty…

LGND

Ligand

$124.16

-0.45 (-0.36%)

SAGE

Sage Therapeutics

$156.08

-0.89 (-0.57%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Mar

SAGE

Sage Therapeutics

$156.08

-0.89 (-0.57%)

05:23
03/20/19
03/20
05:23
03/20/19
05:23
Recommendations
Sage Therapeutics analyst commentary at Piper Jaffray »

Sage Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SMAR

Smartsheet

$43.51

-0.16 (-0.37%)

, SCS

Steelcase

$17.49

-0.115 (-0.65%)

19:06
03/19/19
03/19
19:06
03/19/19
19:06
Hot Stocks
Fly Intel: After Hours Movers »

UP AFTER EARNINGS: …

SMAR

Smartsheet

$43.51

-0.16 (-0.37%)

SCS

Steelcase

$17.49

-0.115 (-0.65%)

AUPH

Aurinia Pharmaceuticals

$6.40

0.13 (2.07%)

NVRO

Nevro

$44.76

0.37 (0.83%)

SAGE

Sage Therapeutics

$156.08

-0.89 (-0.57%)

TME

Tencent Music

$18.65

-0.48 (-2.51%)

WPRT

Westport

$1.50

(0.00%)

AIR

AAR Corp.

$35.10

(0.00%)

FDX

FedEx

$181.50

-0.92 (-0.50%)

FNV

Franco-Nevada

$75.64

0.035 (0.05%)

PRNB

Principia Biopharma

$36.88

0.48 (1.32%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

  • 19

    Mar

  • 19

    Mar

  • 19

    Mar

  • 19

    Mar

  • 19

    Mar

  • 19

    Mar

  • 20

    Mar

  • 20

    Mar

  • 20

    Mar

  • 21

    Mar

  • 01

    Apr

  • 02

    Apr

  • 05

    Apr

  • 14

    May

  • 28

    May

  • 24

    Jun

  • 26

    Jun

SAGE

Sage Therapeutics

$156.08

-0.89 (-0.57%)

19:01
03/19/19
03/19
19:01
03/19/19
19:01
Hot Stocks
Sage says Zulresso approval represents 'game-changing approach' to PPD »

Sage Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

SAGE

Sage Therapeutics

$156.08

-0.89 (-0.57%)

18:04
03/19/19
03/19
18:04
03/19/19
18:04
Hot Stocks
FDA approves Sage Therapeutics' Zulresso in PPD treatment »

The FDA approved Zulresso…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

SAGE

Sage Therapeutics

$156.97

-1.13 (-0.71%)

07:36
03/19/19
03/19
07:36
03/19/19
07:36
Conference/Events
FDA PDUFA Date for Sage Therapeutics ZULRESSO is March 19, 2019 »

Sage Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.